A 2 Part Study to Assess the Relative Bioavailability of Tablet Formulation Compared to Capsule Formulation and the Effect of Food and Taste Assessment on the Tablet Formulation in Healthy Participants

NCT03847987 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: RO7017773 Phase I Capsule
DRUG: RO7017773 Phase II Tablet Unflavored
DRUG: RO7017773 Phase II Tablet Sweetened/Flavored

Sponsor

Hoffmann-La Roche